<DOC>
	<DOC>NCT01055717</DOC>
	<brief_summary>This is a placebo-controlled, crossover study investigating the pharmacokinetic bioavailability of avenanthramides from avenanthramide-enriched oats and their in vivo metabolites in a cohort of healthy, older adults.</brief_summary>
	<brief_title>Bioavailability of Avenanthramide-Enriched Oats in Healthy Older Adults</brief_title>
	<detailed_description />
	<criteria>Men and postmenopausal women BMI 18.529.9 kg/m2 Cigarette smoking and/or nicotine replacement use Use of cholesterollowering medications Use of blood pressurelowering medications Use of any stomach acidlowering medications Cardiovascular (heart) disease Gastrointestinal disease Kidney disease Endocrine disease: including diabetes, untreated thyroid disease Rheumatoid arthritis Active treatment for any type of cancer, except basal cell carcinoma, within 1 year prior to study admission Systolic blood pressure &gt; 150 mm Hg and/or diastolic blood pressure &gt; 95 mm Hg Regular use of oral steroids Regular daily intake of 2 or more alcoholic drinks Illicit drug use No fish oil supplements (including cod liver oil) for one month prior to study admission No dietary supplements, including those containing any vitamins, minerals, herbs, plant concentrates (including garlic, gingko, St. John's wort) or homeopathic remedies, for one month prior to study admission</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>avenanthramide</keyword>
	<keyword>enriched</keyword>
	<keyword>oat</keyword>
	<keyword>phytochemical</keyword>
	<keyword>bioavailability</keyword>
</DOC>